Access cutting-edge merkel cell carcinoma treatment through this clinical trial at a research site in Orange. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Orange location
Access merkel cell carcinoma specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related merkel cell carcinoma treatment provided free
Check if you qualify for this merkel cell carcinoma clinical trial in Orange, CA
No-Cost Study Care
Local to Orange
Convenient for CA residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
This phase II trial compares tuvusertib in combination with avelumab to tuvusertib alone to determine whether the combination therapy will lengthen the time before the cancer starts getting worse in patients with Merkel cell cancer that has not responded to previous treatment (refractory). Tuvusertib is a drug that inhibits an enzyme called ataxia telangiectasia and Rad3 related (ATR) kinase, which is an enzyme that plays a role in repair of damaged deoxyribonucleic acid (DNA) as well as tumor c
Sponsor: National Cancer Institute (NCI)
Yes, this clinical trial (NCT05947500) has an active research site in Orange, CA that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for merkel cell carcinoma treatment options in Orange, CA, this clinical trial (NCT05947500) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Orange research site is actively enrolling participants for this clinical trial. You'll receive care from experienced merkel cell carcinoma specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all merkel cell carcinoma clinical trials near you to find additional studies recruiting in your area.
See all myalgic encephalomyelitis clinical trials recruiting in Orange — not just this study.
Browse Myalgic Encephalomyelitis Trials in Orange →